Metrics as of 10/17/2026, 06:37 AM (Berlin time), refresh in progress.
Amarin Stock
Amarin Corporation plc
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Country
- Ireland
- CEO
- Aaron D. Berg
- Employees
- 80
- Market cap
- $234 M
- IPO
- 01/04/1993
Amarin Corporation plc is a pharmaceutical firm dedicated to the research, development, and commercialization of therapeutic solutions for cardiovascular diseases. Its operations span several international regions, including the United States, Germany, Canada, Lebanon, and the United Arab Emirates. The company's…
Amarin stock: price history
1D
-2.2%
1W
-5.9%
1M
-18.2%
6M
-24.4%
YTD
-18.9%
1Y
-43.6%
2Y
-2.4%
5Y
-89.0%
10Y
-80.9%
Next earnings date
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~8% stronger price swings than usual
Ask the agents about Amarin
Analyst assessment of Amarin
PRICE TARGET LOW
US$1.50
CONSENSUS
US$2.17
MEDIAN
US$2.00
PRICE TARGET HIGH
US$3.00
0
STRONG BUY
3
BUY
13
HOLD
2
SELL
0
STRONG SELL
18
TOTAL · Hold
As of: 25/06/2025
Amarin stock metrics
P/E
-7.92
P/B
0.53
EV/EBITDA
-4.87
RETURN ON EQUITY
-1.7%
NET MARGIN
-18.1%
DEBT/EQUITY
0.01
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
101.0%
FLOAT SHARES
20,893,335
AVG. DAILY VOLUME (30D)
62,630
Insider transactions (SEC)
Fishman Peter L.
Fishman Peter L.
Ketchum Steven B
Ketchum Steven B
Keenan David Paul
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Amarin stock
What does Amarin do?
Amarin Corporation plc is a company in the Healthcare sector, Drug Manufacturers - General industry, headquartered in Ireland.
The CEO is Aaron D. Berg, the company employs around 80 people.
The IPO was on 01/04/1993; the stock trades on NASDAQ under the ticker AMRN.
What do analysts say about Amarin stock?
18 analysts rate the stock, the consensus is Hold (as of 25/06/2025).
The average price target is US$2.17, ranging from US$1.50 to US$3.00, with a median of US$2.00.
This is an external assessment, not a statement by Market Jury.
When does Amarin report next?
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 8% stronger than usual.
Does Amarin pay a dividend?
No, Amarin currently does not pay a dividend.
Which stocks are comparable to Amarin?
Comparable stocks include Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck &, Roche Holding, Amgen, Gilead Sciences and Pfizer.
How can I get Amarin stock analyzed?
Clicking "Analyze stock" lets five strategies assess Amarin against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.